Search Articles

View query in Help articles search

Search Results (1 to 2 of 2 Results)

Download search results: CSV END BibTex RIS

CSV download: Download all 2 search results (up to 5,000 articles maximum)

Seroepidemiological Survey on the Impact of Smoking on SARS-CoV-2 Infection and COVID-19 Outcomes: Protocol for the Troina Study

Seroepidemiological Survey on the Impact of Smoking on SARS-CoV-2 Infection and COVID-19 Outcomes: Protocol for the Troina Study

The biochemically verified smoking status of the study population (ie, serum cotinine) will be correlated with serological data and COVID-19 outcomes (ie, clinical symptoms and hospitalization). Epidemiological exposure data and venous blood (for measurements of anti–SARS-Co V-2–specific Ig G and serum cotinine levels) will be systematically collected.

Riccardo Polosa, Venera Tomaselli, Pietro Ferrara, Alba Corina Romeo, Sonja Rust, Daniela Saitta, Filippo Caraci, Corrado Romano, Murugesan Thangaraju, Pietro Zuccarello, Jed Rose, Giulio Giacomo Cantone, Margherita Ferrante, Jonathan Belsey, Fabio Cibella, Elisa Interlandi, Raffaele Ferri

JMIR Res Protoc 2021;10(11):e32285


A Mobile Health Intervention for Adolescents Exposed to Secondhand Smoke: Pilot Feasibility and Efficacy Study

A Mobile Health Intervention for Adolescents Exposed to Secondhand Smoke: Pilot Feasibility and Efficacy Study

Baseline and follow-up urine samples were analyzed for cotinine by liquid chromatography–tandem mass spectrometry [20]. Cotinine, the main proximate metabolite of nicotine, has a half-life of about 16 hours [19] and is a biomarker of ongoing or recent exposure (past 5-6 days). The limit of quantitation (LOQ) for cotinine was 0.05 ng/m L. Cotinine cutpoints were 0.05-30 ng/m L for light or heavy SHS and >30 ng/m L for active smoking or vaping [5].

Natalie Nardone, Jeremy Giberson, Judith J Prochaska, Shonul Jain, Neal L Benowitz

JMIR Form Res 2020;4(8):e18583